Journal of Prostate Cancer
黑料网
Degarelix
Search results for
Degarelix
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
- Publons
Useful Links
Related Subjects
Share This Page
Degarelix
Degarelix injection is used to treat advanced prostate cancer. Degarelix injection is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone produced by the body. This may slow or stop the spread of prostate cancer cells that need testosterone to grow.
Sexual effect: most of the men lose their sex drive and face problems in erection Skin rashes: mild skin rashes will develop. Weight gain: weight of person will increase
Related Journals of Degarelix
Journal of Prostate Cancer, Journal of Cancer Science & Therapy,